• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长段先天性巨结肠的治疗和结局:APSA 结果和循证实践委员会的系统评价。

Management and outcomes for long-segment Hirschsprung disease: A systematic review from the APSA Outcomes and Evidence Based Practice Committee.

机构信息

Department of Pediatric Surgery, University of Texas Health Science Center at Houston, Houston, TX, USA.

Department of Surgery University of California Irvine and Division of Pediatric Surgery Children's Hospital of Orange County, USA.

出版信息

J Pediatr Surg. 2021 Sep;56(9):1513-1523. doi: 10.1016/j.jpedsurg.2021.03.046. Epub 2021 Mar 28.

DOI:
10.1016/j.jpedsurg.2021.03.046
PMID:33993978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8552809/
Abstract

OBJECTIVE

Long-Segment Hirschsprung Disease (LSHD) differs clinically from short-segment disease. This review article critically appraises current literature on the definition, management, outcomes, and novel therapies for patients with LSHD.

METHODS

Four questions regarding the definition, management, and outcomes of patients with LSHD were generated. English-language articles published between 1990 and 2018 were compiled by searching PubMed, Scopus, Cochrane Central Register of Controlled Trials, Web of Science, and Google Scholar. A qualitative synthesis was performed.

RESULTS

66 manuscripts were included in this systematic review. Standardized nomenclature and preoperative evaluation for LSHD are recommended. Insufficient evidence exists to recommend a single method for the surgical repair of LSHD. Patients with LSHD may have increased long-term gastrointestinal symptoms, including Hirschsprung-associated enterocolitis (HAEC), but have a quality of life similar to matched controls. There are few surgical technical innovations focused on this disorder.

CONCLUSIONS

A standardized definition of LSHD is recommended that emphasizes the precise anatomic location of aganglionosis. Prospective studies comparing operative options and long-term outcomes are needed. Translational approaches, such as stem cell therapy, may be promising in the future for the treatment of long-segment Hirschsprung disease.

摘要

目的

长段先天性巨结肠病(LSHD)在临床上与短段疾病不同。本文批判性地评价了目前关于 LSHD 患者定义、治疗、结局和新疗法的文献。

方法

针对 LSHD 患者的定义、管理和结局提出了 4 个问题。通过检索 PubMed、Scopus、Cochrane 中央对照试验注册中心、Web of Science 和 Google Scholar 等数据库,收集了 1990 年至 2018 年发表的英文文献。采用定性综合分析法进行分析。

结果

本系统评价共纳入 66 篇文献。建议采用标准化的命名和术前评估方法。对于 LSHD 的手术修复,目前尚无单一方法的充分证据支持。LSHD 患者可能存在长期的胃肠道症状,包括先天性巨结肠相关性结肠炎(HAEC),但其生活质量与匹配对照组相似。目前针对该疾病的手术技术创新较少。

结论

建议采用标准化的 LSHD 定义,强调神经节细胞缺失的确切解剖位置。需要开展比较手术选择和长期结局的前瞻性研究。未来,干细胞疗法等转化方法可能有望成为长段先天性巨结肠病的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe71/8552809/a3459d3f457c/nihms-1748482-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe71/8552809/d7a240d2d784/nihms-1748482-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe71/8552809/a3459d3f457c/nihms-1748482-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe71/8552809/d7a240d2d784/nihms-1748482-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe71/8552809/a3459d3f457c/nihms-1748482-f0002.jpg

相似文献

1
Management and outcomes for long-segment Hirschsprung disease: A systematic review from the APSA Outcomes and Evidence Based Practice Committee.长段先天性巨结肠的治疗和结局:APSA 结果和循证实践委员会的系统评价。
J Pediatr Surg. 2021 Sep;56(9):1513-1523. doi: 10.1016/j.jpedsurg.2021.03.046. Epub 2021 Mar 28.
2
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
7
Nifedipine for primary dysmenorrhoea.硝苯地平治疗原发性痛经。
Cochrane Database Syst Rev. 2021 Dec 18;12(12):CD012912. doi: 10.1002/14651858.CD012912.pub2.
8
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.

引用本文的文献

1
Comparison of robotic-assisted and laparoscopic-assisted surgery in the treatment of children with Hirschsprung's disease: a systematic review and meta-analysis.机器人辅助手术与腹腔镜辅助手术治疗先天性巨结肠患儿的比较:系统评价与Meta分析
Front Pediatr. 2025 Aug 6;13:1638198. doi: 10.3389/fped.2025.1638198. eCollection 2025.
2
Features of defecation dysfunction among patients with Hirschsprung disease in early childhood.幼儿期先天性巨结肠症患者排便功能障碍的特征。
BMC Gastroenterol. 2025 Jul 9;25(1):510. doi: 10.1186/s12876-025-04106-4.
3
Does the absence of hypertrophic nerves on rectal biopsy predict long-segment or total colonic aganglionosis?

本文引用的文献

1
Diagnosis of Hirschsprung Disease.先天性巨结肠症的诊断
Pediatr Dev Pathol. 2020 Jan-Feb;23(1):8-22. doi: 10.1177/1093526619892351. Epub 2019 Dec 2.
2
Guidelines for synoptic reporting of surgery and pathology in Hirschsprung disease.先天性巨结肠病手术和病理学报告要点。
J Pediatr Surg. 2019 Oct;54(10):2017-2023. doi: 10.1016/j.jpedsurg.2019.03.010. Epub 2019 Mar 21.
3
Hirschsprung disease and Down syndrome: From the reappraisal of risk factors to the impact of surgery.先天性巨结肠症与唐氏综合征:从风险因素的再评估到手术的影响。
直肠活检时无肥厚神经能否预测长段或全结肠无神经节细胞症?
Pediatr Surg Int. 2025 Jun 4;41(1):158. doi: 10.1007/s00383-025-06060-4.
4
Histopathologic Concerns and Diagnostic Challenges in Hirschsprung's Disease: An Eastern European Single-Center Observational Study.先天性巨结肠症的组织病理学问题与诊断挑战:一项东欧单中心观察性研究
Life (Basel). 2025 Feb 20;15(3):329. doi: 10.3390/life15030329.
5
Surgical management of short-segment Hirschsprung disease.短段型先天性巨结肠的外科治疗
World J Pediatr Surg. 2024 Dec 31;7(4):e000916. doi: 10.1136/wjps-2024-000916. eCollection 2024.
6
Prevalence and Factors associated with Bowel Dysfunctions after Pull-Through Surgery in Children Diagnosed with Hirschsprung Disease.先天性巨结肠症患儿拖出式手术后肠道功能障碍的患病率及相关因素
Pediatr Gastroenterol Hepatol Nutr. 2024 Nov;27(6):372-382. doi: 10.5223/pghn.2024.27.6.372. Epub 2024 Nov 5.
7
Long-term outcomes and quality of life in patients with Hirschsprung disease.先天性巨结肠症患者的长期预后及生活质量
World J Pediatr Surg. 2024 Oct 9;7(3):e000859. doi: 10.1136/wjps-2024-000859. eCollection 2024.
8
Hirschsprung-associated enterocolitis: a comprehensive review.先天性巨结肠相关小肠结肠炎:全面综述
World J Pediatr Surg. 2024 Oct 14;7(3):e000878. doi: 10.1136/wjps-2024-000878. eCollection 2024.
9
Genetic association of with long-segment Hirschsprung's disease in southern Chinese children.与中国南方儿童长段先天性巨结肠症的基因关联。
Transl Pediatr. 2024 Aug 31;13(8):1395-1405. doi: 10.21037/tp-24-153. Epub 2024 Aug 28.
10
Hirschsprung disease: common and uncommon variants.先天性巨结肠症:常见及罕见变体
World J Pediatr Surg. 2024 Aug 28;7(3):e000864. doi: 10.1136/wjps-2024-000864. eCollection 2024.
J Pediatr Surg. 2019 Sep;54(9):1838-1842. doi: 10.1016/j.jpedsurg.2019.01.053. Epub 2019 Feb 12.
4
Long-term functional outcomes and quality of life in patients with Hirschsprung's disease.先天性巨结肠症患者的长期功能结果和生活质量。
Br J Surg. 2019 Mar;106(4):499-507. doi: 10.1002/bjs.11059. Epub 2019 Jan 17.
5
The long-term quality of life outcomes in adolescents with Hirschsprung disease.先天性巨结肠症青少年的长期生活质量结果
J Pediatr Surg. 2018 Dec;53(12):2430-2434. doi: 10.1016/j.jpedsurg.2018.08.036. Epub 2018 Sep 5.
6
Surgical treatment of children with total colonic aganglionosis: functional and metabolic long-term outcome.全结肠无神经节细胞症患儿的外科治疗:长期功能和代谢转归
BMC Surg. 2018 Aug 15;18(1):58. doi: 10.1186/s12893-018-0383-6.
7
Single-stage laparoscopic transanal pull-through modified Swenson procedure without leaving a muscular cuff for short- and long-type Hirschsprung disease: a comparative study.单阶段腹腔镜经肛门拖出改良Swenson手术治疗短型和长型先天性巨结肠不保留肌袖:一项比较研究
Pediatr Surg Int. 2018 Oct;34(10):1105-1110. doi: 10.1007/s00383-018-4318-1. Epub 2018 Aug 2.
8
Correction to: Functional outcomes in Hirschsprung disease patients after transabdominal Soave and Duhamel procedures.对《经腹Soave和Duhamel手术后先天性巨结肠症患者的功能结局》的更正
BMC Gastroenterol. 2018 Jul 9;18(1):110. doi: 10.1186/s12876-018-0844-5.
9
Long-term outcome and quality of life in patients with total colonic aganglionosis in the Netherlands.荷兰全结肠无神经节细胞症患者的长期预后和生活质量。
Colorectal Dis. 2018 Aug;20(8):719-726. doi: 10.1111/codi.14095.
10
Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.先天性巨结肠症——整合基础科学和临床医学以改善治疗效果。
Nat Rev Gastroenterol Hepatol. 2018 Mar;15(3):152-167. doi: 10.1038/nrgastro.2017.149. Epub 2018 Jan 4.